Biotech Law

Systems biotechnology of animal cells: the road to prediction

Nuno Carinhas, Rui Oliveira, Paula Marques Alves, Manuel J.T. Carrondo, Ana P. Teixeira. A central concern of biopharmaceutical R&D is the production of sufficient quantities of recombinant products from manufacturing processes based on animal cell culture. The way in which … Continue reading

Virus scaffolds as enzyme nano-carriers

Daniela Cardinale, Noëlle Carette, Thierry Michon. The cooperative organization of enzymes by cells is a key feature for the efficiency of living systems. In the field of nanotechnologies, effort currently aims at mimicking this natural organizati….

Precision genetic engineering in large mammals

Wiebke Garrels, Zoltan Ivics, Wilfried A. Kues. Precision genetic engineering based on stable chromosomal insertion of exogenous DNA in the genomes of large mammals is immensely important for the development of improved biomedical models, pharm….

Law of Nature or Patentable Discovery? Supreme Court’s Mayo v. Prometheus Decision Raises More Questions for Personalized Medicine – jdsupra.com

As published in Genetic Engineering & Biotechnology News, May 1 … that including transformative steps would qualify a method of harnessing a natural law or abstract idea into a patentable application. The first aftershocks of this decision were felt …

While Europe enjoys cheap biotech drugs, U.S. waits on FDA – Forbes

While the U.S. government works out final regulations to bring cheaper copies of expensive drugs derived from biotechnology to patients here … not part of the landmark 1984 Hatch-Waxman law, which cleared a regulatory path for cheaper generic …

Biotech Firm Amyris Shakes up In-House Department – Law.com

Oh, the perils of working at a high-tech startup company. Tamara Tompkins, until this week the general counsel of the biotech firm Amyris Inc., found out the hard way. Data for Lawfirms, Companies, and Agencies is unavailable for this article.

In-House Shakeup at Biotech Energy Firm Amyris – Law.com

Tamara Tompkins, until this week the general counsel of the biotech firm Amyris Inc., found out the hard … Prior to joining Genentech in 2000, Loeb practiced general intellectual property law in Los Angeles and San Francisco.

California public to vote on GMO Label Act; Biotech lies begin – The People’s Voice

“Even biotech engineers gathered signatures for us … to Know Genetically Engineered Food Act on the ballot for November 6, and passed into law. Money raised in this Million Dollar Money Bomb on Monsanto campaign will support the California …

Obesity Related Health Care Costs Total $190 Billion a Year — Orexigen and Human Genome Look to Take Advantage – msnbc.com

Biotech companies are in a race to bring the first weight-loss … mounted toilets with floor models to support obese patients. The U.S. health care reform law of 2010 allows obese employees to be charged between 30 to 50 percent … Continue reading

Arena Pharmaceuticals and VIVUS Look to Cash in on Anti-Obesity Drug Market – msnbc.com

Biotech companies are in a race to bring the first weight-loss … mounted toilets with floor models to support obese patients. The U.S. health care reform law of 2010 allows obese employees to be charged between 30 to 50 percent … Continue reading